Jan Egbert de Vries

Jan Egbert de Vries

Chairman at Artax, Inc.

79 year
Health Technology
Consumer Services
Commercial Services

Profile

Jan Egbert de Vries founded Tr1x, Inc. Currently, he is Chairman of Artax, Inc. In the past he held the position of Chairman for AIMM Therapeutics BV, Chief Executive Officer of Tr1x, Inc., Senior VP-Drug Discovery & Early Development at Novartis AG and Head at Novartis Institutes for Biomedical Research, Inc. (a subsidiary of Novartis AG), Independent Director at Cassiopea SpA, Director-Human Immunology Department at DNAX Research, Inc. and Head-Immunology Department at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh.
Dr. De Vries received a doctorate from the University of Amsterdam and a graduate degree from the University of Utrecht.

Jan Egbert de Vries active positions

CompaniesPositionStart
Artax, Inc. Chairman -
All active positions of Jan Egbert de Vries

Former positions of Jan Egbert de Vries

CompaniesPositionEnd
Chief Executive Officer 2024-01-16
Chief Executive Officer 2017-12-30
Corporate Officer/Principal 2009-12-31
NOVARTIS AG Corporate Officer/Principal 2008-12-31
DNAX Research, Inc. Corporate Officer/Principal 1996-12-31
See the detail of Jan Egbert de Vries's experience

Training of Jan Egbert de Vries

University of Amsterdam Doctorate Degree
University of Utrecht Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jan Egbert de Vries's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NOVARTIS AG

Health Technology

Private companies8

Commercial Services

Health Technology

Health Technology

DNAX Research, Inc.

Miscellaneous

Health Technology

Artax, Inc.

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Jan Egbert de Vries